Your Pain Meds’ Side Effects May Be Masquerading as Heart Failure
Matthew Growdon's study finds "prescription cascades" where drug side effects lead to unnecessary second prescriptions, causing further harm and costly hospitalizations.
University of California San Francisco
Could This Precision Medicine Approach Help You Delay Dementia?
A UCSF-led study reveals combining genetic risk factors like APOE4 with cardiovascular risks such as high LDL, obesity, and hypertension can predict dementia likelihood. Lifestyle changes targeting modifiable risks may delay or prevent symptoms, offering hope for proactive dementia prevention strategies.
Why a Foreign Language Sounds Like a Blur to Non-Native Ears
Scientists have thought that when we hear language, the brain processes it the same way, whether it's familiar or foreign. A new study reveals that exposure to a language changes how certain clusters of neurons respond to the familiar sounds. From those changes, we develop the understanding of syllables, words, and syntax.
Improving Management and Treatment of Thyroid Cancer
Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid cancer (DTC) to provide clinicians, patients, and researchers with a comprehensive and objective set of the latest management options for the disease.
Texting Helps UCSF Reach More Patients with Needed Care
Using a mix of outreach methods – texts, automated calls, and live phone calls – can improve follow-up care for discharged patients, especially hard-to-reach groups. UCSF Health’s study found this approach significantly boosts engagement and reduces disparities in care, particularly among African American patients.
From Undruggable to Unstoppable: A New Cancer Cure Target Emerges
The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny “pocket” on a protein that signals the cells to grow and divide was discovered, leading to the world's first FDA-approved drugs that can now target and destroy these cancer cells.
UCSF Cardiologists Share Research, Receive Recognition at Heart Meeting
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San Francisco clinicians and researchers at the American Heart Association’s Scientific Sessions 2025. The meeting, taking place from Nov. 7 to 10 in New Orleans, Louisiana, is the premier global event in cardiovascular health and science.
How to Thwart Cancer: Drug the Cells It Uses to Grow and Shapeshift
Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting.
Until now, it was not clear whether the cells promote cancer inside the body. Now we know they do, and how.
How Can AI Sentiment Analysis Apply to Complex Medical Diagnoses?
UCSF researchers are studying whether large language models, a type of artificial intelligence (AI), can analyze the clinical notes of multiple physicians and other care providers to improve the diagnosis of complex liver conditions like hepatorenal syndrome (HRS).
New Healthy, Hopeful, Care Guidelines for Pregnant Women with IBD
Women with inflammatory bowel disease (IBD) face increased pregnancy risks, often leading to confusion and fear. UCSF’s PIANO study and global guidelines highlight safe medication use, debunk myths, and improve care.